메뉴 건너뛰기




Volumn 2 DEC, Issue , 2011, Pages

The importance of being profiled: Improving drug candidate safety and efficacy using ion channel profiling

Author keywords

Ion channel

Indexed keywords

BATRACHOTOXIN; CALCIUM CHANNEL VOLTAGE 1.2; CARBAMAZEPINE; FLECAINIDE; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR2.1; ION CHANNEL; LAMOTRIGINE; LIDOCAINE; OMEGA CONOTOXIN; PHENYTOIN; POTASSIUM CHANNEL KCNQ1; POTASSIUM CHANNEL KV11.1; POTASSIUM CHANNEL KV4.2; POTASSIUM CHANNEL KV4.3; RILUZOLE; SHAB POTASSIUM CHANNEL; SHAKER POTASSIUM CHANNEL; SHAL POTASSIUM CHANNEL; SHAW POTASSIUM CHANNEL; SODIUM CHANNEL NAV1.2; SODIUM CHANNEL NAV1.5; SODIUM CHANNEL NAV1.6; TETRACAINE; TETRODOTOXIN; UNCLASSIFIED DRUG;

EID: 84858758112     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2011.00078     Document Type: Article
Times cited : (24)

References (40)
  • 2
    • 0020624782 scopus 로고
    • Lidocaine block of sodium channels
    • Bean, B. P., Cohen, C. J., and Tsien, R. W. (1983). Lidocaine block of sodium channels. J. Gen. Physiol. 81, 613-642.
    • (1983) J. Gen. Physiol. , vol.81 , pp. 613-642
    • Bean, B.P.1    Cohen, C.J.2    Tsien, R.W.3
  • 3
    • 77953405501 scopus 로고    scopus 로고
    • Smallmolecule modulators of inward rectifier K+ channels: recent advances and future possibilities
    • Bhave, G., Lonergan, D., Chauder, B. A. II., and Denton, J. S. (2010). Smallmolecule modulators of inward rectifier K+ channels: recent advances and future possibilities. Future Med. Chem. 2, 757-774.
    • (2010) Future Med. Chem. , vol.2 , pp. 757-774
    • Bhave, G.1    Lonergan, D.2    Chauder, B.A.3    Denton II., J.S.4
  • 4
    • 76749151845 scopus 로고    scopus 로고
    • Prediction of drug-induced cardiotoxicity using human embryonic stem cellderived cardiomyocytes
    • Braam, S. R., Tertoolen, L., van de Stolpe, A., Meyer, T., Passier, R., andMummery, C. L. (2010). Prediction of drug-induced cardiotoxicity using human embryonic stem cellderived cardiomyocytes. Stem Cell Res. 4, 107-116.
    • (2010) Stem Cell Res , vol.4 , pp. 107-116
    • Braam, S.R.1    Tertoolen, L.2    van de Stolpe, A.3    Meyer, T.4    Passier, R.5    Mummery, C.L.6
  • 5
    • 0037198957 scopus 로고    scopus 로고
    • Molecular cloning, distribution and functional analysis of the Na(V)1.6. voltage-gated sodium channel from human brain
    • Burbidge, S. A., Dale, T. J., Powell, A. J., Whitaker, W. R., Xie, X. M., Romanos, M. A., and Clare, J. J. (2002). Molecular cloning, distribution and functional analysis of the Na(V)1.6. voltage-gated sodium channel from human brain. Brain Res. Mol. Brain Res. 103, 80-90.
    • (2002) Brain Res. Mol Brain Res. , vol.103 , pp. 80-90
    • Burbidge, S.A.1    Dale, T.J.2    Powell, A.J.3    Whitaker, W.R.4    Xie, X.M.5    Romanos, M.A.6    Clare, J.J.7
  • 8
    • 77955324516 scopus 로고    scopus 로고
    • Novel structure-activity relationships and selectivity profiling of cage dimeric 1 4-dihydropyridines as multidrug resistance (MDR) modulators
    • Coburger, C., Wollmann, J., Krug, M., Baumert, C., Seifert, M., Molnár, J., Lage, H., and Hilgeroth, A. (2010). Novel structure-activity relationships and selectivity profiling of cage dimeric 1,4-dihydropyridines as multidrug resistance (MDR) modulators. Bioorg. Med. Chem. 18, 4983-4990.
    • (2010) Bioorg. Med. Chem. , vol.18 , pp. 4983-4990
    • Coburger, C.1    Wollmann, J.2    Krug, M.3    Baumert, C.4    Seifert, M.5    Molnár, J.6    Lage, H.7    Hilgeroth, A.8
  • 11
    • 0038471102 scopus 로고    scopus 로고
    • The impact of drug-induced QT interval prolongation on drug discovery and development
    • Fermini, B., and Fossa, A. A. (2003). The impact of drug-induced QT interval prolongation on drug discovery and development. Nat. Rev. Drug Discov. 2, 439-447.
    • (2003) Nat. Rev. Drug Discov. , vol.2 , pp. 439-447
    • Fermini, B.1    Fossa, A.A.2
  • 12
    • 34547869800 scopus 로고    scopus 로고
    • Highconductance calcium-activated potassium channels: validated targets for smoothmuscle relaxants?
    • Garcia, M. L., Shen, D.-M., and Kaczorowski, G. J. (2007). Highconductance calcium-activated potassium channels: validated targets for smoothmuscle relaxants? Expert Opin. Ther. Pat. 17, 1-12.
    • (2007) Expert Opin Ther. Pat. , vol.17 , pp. 1-12
    • Garcia, M.L.1    Shen, D.-M.2    Kaczorowski, G.J.3
  • 14
    • 74949143771 scopus 로고    scopus 로고
    • Inwardly rectifying potassium channels: their structure, function, and physiological roles
    • Hibino, H., Inanobe, A., Furutani, K., Murakami, S., Findlay, I., and Kurachi, Y. (2010). Inwardly rectifying potassium channels: their structure, function, and physiological roles. Physiol. Rev. 90, 291-366.
    • (2010) Physiol. Rev. , vol.90 , pp. 291-366
    • Hibino, H.1    Inanobe, A.2    Furutani, K.3    Murakami, S.4    Findlay, I.5    Kurachi, Y.6
  • 15
    • 0017726385 scopus 로고
    • Time- and voltagedependent interactions of antiarrythmic drugs with cardiac sodium channels
    • Hondeghem, L. M., and Katzung, B. G. (1977). Time- and voltagedependent interactions of antiarrythmic drugs with cardiac sodium channels. Biochem. Biophys. Acta 472, 373-398.
    • (1977) Biochem. Biophys. Acta , vol.472 , pp. 373-398
    • Hondeghem, L.M.1    Katzung, B.G.2
  • 16
  • 18
    • 39749149703 scopus 로고    scopus 로고
    • A genetic framework for improving arrhythmia therapy
    • Knollmann, B. C., and Roden, D. M. (2008). A genetic framework for improving arrhythmia therapy. Nature 451, 929-936.
    • (2008) Nature , vol.451 , pp. 929-936
    • Knollmann, B.C.1    Roden, D.M.2
  • 19
    • 79955844082 scopus 로고    scopus 로고
    • Electrophysiologic, pharmacokinetic, and pharmacodynamic values indicating a higher risk of torsades de pointes
    • Lin, Y. L., Hsiao, C. L., Wu, Y. C., and Kung, M. F. (2011). Electrophysiologic, pharmacokinetic, and pharmacodynamic values indicating a higher risk of torsades de pointes. J. Clin. Pharmacol. 51, 819-829.
    • (2011) J. Clin. Pharmacol. , vol.51 , pp. 819-829
    • Lin, Y.L.1    Hsiao, C.L.2    Wu, Y.C.3    Kung, M.F.4
  • 20
    • 48149084580 scopus 로고    scopus 로고
    • Predicting drug-induced changes in QT interval and arrhythmias: QT-shortening drugs point to gaps in the ICHS7B Guidelines
    • Lu, H. R., Vlaminckx, E., Hermans, A. N., Rohrbacher, J., Van Ammel, K., Towart, R., Pugsley, M., and Gallacher, D. J. (2008). Predicting drug-induced changes in QT interval and arrhythmias: QT-shortening drugs point to gaps in the ICHS7B Guidelines. Br. J. Pharmacol. 154, 1427-1438.
    • (2008) Br. J. Pharmacol. , vol.154 , pp. 1427-1438
    • Lu, H.R.1    Vlaminckx, E.2    Hermans, A.N.3    Rohrbacher, J.4    Van Ammel, K.5    Towart, R.6    Pugsley, M.7    Gallacher, D.J.8
  • 21
    • 33645780149 scopus 로고    scopus 로고
    • QPatch: the past, present and future of automated patch clamp
    • Mathes, C. (2006). QPatch: the past, present and future of automated patch clamp. Expert Opin. Ther. Targets 10, 319-327.
    • (2006) Expert Opin. Ther. Targets , vol.10 , pp. 319-327
    • Mathes, C.1
  • 22
    • 33751527644 scopus 로고    scopus 로고
    • Innovative approaches to antiarrhythmic drug therapy
    • Nattel, S., and Carlsson, L. (2006). Innovative approaches to antiarrhythmic drug therapy. Nat. Rev. 5, 1034-1049.
    • (2006) Nat. Rev. , vol.5 , pp. 1034-1049
    • Nattel, S.1    Carlsson, L.2
  • 23
    • 77952554233 scopus 로고    scopus 로고
    • To the editor-market withdrawal of quinidine bisulfate (Kinidin Durules) in 2006
    • Olsson, G. (2010). To the editor-market withdrawal of quinidine bisulfate (Kinidin Durules) in 2006. Heart Rhythm 7, 864.
    • (2010) Heart Rhythm , vol.7 , pp. 864
    • Olsson, G.1
  • 27
    • 80053588007 scopus 로고    scopus 로고
    • Functional selectivity at the μ-opioid receptor: implications for understanding opioid analgesia and tolerance
    • Raehal, K. M., Schmid, C. L., Groer, C. E., and Bohn, L. M. (2011). Functional selectivity at the μ-opioid receptor: implications for understanding opioid analgesia and tolerance. Pharmacol. Rev. 63, 1001-1019.
    • (2011) Pharmacol. Rev. , vol.63 , pp. 1001-1019
    • Raehal, K.M.1    Schmid, C.L.2    Groer, C.E.3    Bohn, L.M.4
  • 28
    • 0344492207 scopus 로고    scopus 로고
    • Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development
    • Redfern, W., Carlsson, L., and Davis, A. S., Lynch, W. G., MacKenzie, I., Palethorpe, S., Siegl, P. K. S., Strang, I., Sullivan, A. T., Wallis, R., Camm, A. J., and Hammond, T. G. (2003). Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development. Cardiovasc. Res. 58, 32-45.
    • (2003) Cardiovasc. Res. , vol.58 , pp. 32-45
    • Redfern, W.1    Carlsson, L.2    Davis, A.S.3    Lynch, W.G.4    MacKenzie, I.5    Palethorpe, S.6    Siegl, P.K.S.7    Strang, I.8    Sullivan, A.T.9    Wallis, R.10    Camm, A.J.11    Hammond, T.G.12
  • 30
    • 1442306232 scopus 로고    scopus 로고
    • Drug-induced prolongation of the QT interval
    • Roden, D. M. (2004). Drug-induced prolongation of the QT interval. N. Engl. J. Med. 350, 1013-1022.
    • (2004) N. Engl. J. Med. , vol.350 , pp. 1013-1022
    • Roden, D.M.1
  • 31
    • 80052274158 scopus 로고    scopus 로고
    • Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes
    • Rudolph, U., and Knoflach, F. (2011). Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes. Nat. Rev. Drug Discov. 10, 685-697.
    • (2011) Nat. Rev. Drug Discov. , vol.10 , pp. 685-697
    • Rudolph, U.1    Knoflach, F.2
  • 32
    • 84874948346 scopus 로고    scopus 로고
    • Available at
    • Sanofi Aventis. (2011). Available at: http://online.wsj.com/article/BT-CO -20110215-704422.html
    • (2011)
    • Aventis, S.1
  • 35
    • 49249134845 scopus 로고    scopus 로고
    • Automated patch-clamp technique: increased throughput in functional characterization and in pharmacological screening of smallconductance Ca2+ release-activated Ca2+ channels
    • Schrøder, R. L., Friis, S., Sunesen, M., Mathes, C., and Willumsen, N. J. (2008). Automated patch-clamp technique: increased throughput in functional characterization and in pharmacological screening of smallconductance Ca2+ release-activated Ca2+ channels. J. Biomol. Screen 13, 638-647.
    • (2008) J. Biomol. Screen , vol.13 , pp. 638-647
    • Schrøder, R.L.1    Friis, S.2    Sunesen, M.3    Mathes, C.4    Willumsen, N.J.5
  • 36
    • 33749027737 scopus 로고    scopus 로고
    • Can pharmacogenetics help rescue drugs withdrawn fromthe market?
    • Shah, R. R. (2006). Can pharmacogenetics help rescue drugs withdrawn fromthe market? Pharmacogenomics 7, 889-908.
    • (2006) Pharmacogenomics , vol.7 , pp. 889-908
    • Shah, R.R.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.